|
|
| 2023, Vol. 32(1): 75-80 DOI: 10.3760/cma.j.cn113030-20211117-00469 | ||
| Research progress on recombinant human endostatin combined with radiotherapy and / or chemotherapy in the treatment of cervical cancer | ||
| Li Xin1,2, Hu Lijun2, Yu Jingping1,2,3 | ||
| 1Graduate School of Bengbu Medical College,Bengbu 233000, China; 2Department of radiotherapy, Changzhou No.2 People's Hospital, the Affiliated Hospital of Nanjing Medical University, Changzhou 213003, China; 3Department of radiotherapy, Shuguang Hospital, the Affiliated Hospital of Shanghai University of Chinese Traditional Medicine, Shanghai 201203, China |
||
| Received 2021-11-17 Revised null | ||
| Supporting info | ||
| null | ||
|
